全文获取类型
收费全文 | 12942篇 |
免费 | 641篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 171篇 |
儿科学 | 377篇 |
妇产科学 | 352篇 |
基础医学 | 1616篇 |
口腔科学 | 304篇 |
临床医学 | 758篇 |
内科学 | 3504篇 |
皮肤病学 | 407篇 |
神经病学 | 859篇 |
特种医学 | 198篇 |
外科学 | 1709篇 |
综合类 | 133篇 |
一般理论 | 2篇 |
预防医学 | 1390篇 |
眼科学 | 232篇 |
药学 | 887篇 |
中国医学 | 79篇 |
肿瘤学 | 637篇 |
出版年
2023年 | 87篇 |
2022年 | 81篇 |
2021年 | 282篇 |
2020年 | 150篇 |
2019年 | 342篇 |
2018年 | 509篇 |
2017年 | 289篇 |
2016年 | 304篇 |
2015年 | 283篇 |
2014年 | 368篇 |
2013年 | 534篇 |
2012年 | 880篇 |
2011年 | 942篇 |
2010年 | 508篇 |
2009年 | 360篇 |
2008年 | 788篇 |
2007年 | 818篇 |
2006年 | 852篇 |
2005年 | 806篇 |
2004年 | 737篇 |
2003年 | 712篇 |
2002年 | 655篇 |
2001年 | 379篇 |
2000年 | 457篇 |
1999年 | 328篇 |
1998年 | 72篇 |
1997年 | 55篇 |
1996年 | 41篇 |
1995年 | 29篇 |
1994年 | 33篇 |
1993年 | 34篇 |
1992年 | 104篇 |
1991年 | 88篇 |
1990年 | 102篇 |
1989年 | 70篇 |
1988年 | 59篇 |
1987年 | 63篇 |
1986年 | 62篇 |
1985年 | 46篇 |
1984年 | 24篇 |
1983年 | 28篇 |
1982年 | 17篇 |
1980年 | 14篇 |
1979年 | 14篇 |
1978年 | 18篇 |
1976年 | 14篇 |
1974年 | 14篇 |
1973年 | 16篇 |
1971年 | 20篇 |
1969年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
241.
The involvement of the renin-angiotensin system gene polymorphisms in coronary heart disease 总被引:1,自引:0,他引:1
Hernández Ortega E Medina Fernández-Aceituno A Rodríguez Esparragón FJ Hernández Perera O Melián Nuez F Delgado Espinosa A Fíuza Pérez D Anabitarte Prieto A Rodríguez Pérez JC 《Revista espa?ola de cardiología》2002,55(2):92-99
INTRODUCTION AND OBJECTIVES: Previous studies angiotensin-converting enzyme gene insertion/deletion polymorphism ACE (I/D), angiotensinogen gene polymorphism, and angiotensin II AT1 receptor polymorphism in relation to coronary heart disease controversial results. This study was designed to analyze the association between these gene polymorphisms and the first coronary event in individuals residing on Grand Canary Island, Spain. PATIENTS AND METHOD: Case-control study. Case subjects (n = 304) were recruited at the first coronary event; age-matched controls (n = 315) were randomly selected from the Grand Canary population. Participants were examined for the usual risk factors. Blood samples were obtained for biochemical analyses and DNA extraction. Genotyping was performed by PCR and restriction analysis. RESULTS: Neither ACE (I/D) nor AT1 receptor polymorphism was associated with coronary heart disease, whereas the frequency distribution of AGT M235T genotypes among patients and control subjects (TT: 29% and 19%; MT: 48% and 50%; MM: 22% and 31%, respectively) was statistically different (p = 0.003). Multiple logistic regression analysis identified the TT genotype of the angiotensinogen gene (OR = 1.9; 95% CI 1.1-3.4), diabetes (OR = 4.4; 95% CI 2.0-9.4) and hypertension (OR = 2.1; 95% CI 1.3-3.3) as risk factors predicting the coronary event. CONCLUSIONS: Our results provide no evidence of an association between ACE (I/D) or AT1 receptor polymorphism and coronary heart disease. However, homozygosity for the T allele of the angiotensinogen gene, diabetes and hypertension independently place individuals at higher risk of experiencing a coronary event on Grand Canary Island. 相似文献
242.
Mateos MV Hernández JM Hernández MT Gutiérrez NC Palomera L Fuertes M Garcia-Sanchez P Lahuerta JJ de la Rubia J Terol MJ Sureda A Bargay J Ribas P Alegre A de Arriba F Oriol A Carrera D García-Laraña J García-Sanz R Bladé J Prósper F Mateo G Esseltine DL van de Velde H San Miguel JF 《Haematologica》2008,93(4):560-565
243.
Carmona L Hernández-García C Vadillo C Pato E Balsa A González-Alvaro I Belmonte MA Tena X Sanmartí R;EMECAR Study Group 《The Journal of rheumatology》2003,30(7):1436-1439
OBJECTIVE: To quantify the risk of tuberculosis (TB) in an unselected sample of patients with rheumatoid arthritis (RA) compared to the risk in the general population. METHODS: The incidence of TB in the general population of Spain was obtained from the National Network of Epidemiological Surveillance reports. The incidence of TB was ascertained from a cohort of 788 patients with RA selected randomly from the registries of 34 participating centers throughout Spain. A patient was considered a TB case only if information about disease symptoms, microorganism identification, and TB treatment were confirmed in the clinical records. The relative risk of TB in RA was calculated by dividing the standardized mean incidence of TB from 1990 to 2000 in the RA cohort by the mean incidence of TB in Spain during the same years. RESULTS: The mean incidence of TB in the general population of Spain from 1990 to 2000 was 23 cases per 100,000. Seven cases of TB were identified in the RA cohort, yielding a mean annual incidence (1990-2000) of 134/100,000 patients. The incidence risk ratio of pulmonary TB in patients with RA compared to the general population is 3.68 (95% CI 2.36-5.92). CONCLUSION: We found a 4-fold increased risk of TB infection in patients diagnosed with RA. These results might help to interpret the magnitude of the problem attributable to the introduction of new therapies in RA. 相似文献
244.
245.
Sarah M Cahill I Kaye Wachsmuth Maria de Lourdes Costarrica Peter Karim Ben Embarek 《Clinical infectious diseases》2008,46(2):268-273
Powdered infant formula is not sterile and may be intrinsically contaminated with pathogens, such as Salmonella enterica, that can cause serious illness in infants. In recent years, at least 6 outbreaks of Salmonella infection in infants that have been linked to the consumption of powdered infant formula have been reported. Many of these outbreaks were identified because the Salmonella strains were unique in some way (e.g., a rare serotype) and a well-established Salmonella surveillance network, supported by laboratories capable of serotyping isolates, was in place. Another common feature of the outbreaks was the low level of salmonellae detected in the implicated formula (salmonellae may be missed in routine testing). These outbreaks likely represent only a small proportion of the actual number of Salmonella infections in infants that have been linked to powdered infant formula. Managing this problem requires a multidimensional approach in which manufacturers, regulators, and caregivers to infants can all play a role. 相似文献
246.
Itziar Lamiquiz-Moneo Fernando Civeira Rocío Mateo-Gallego Martín Laclaustra Belén Moreno-Franco María Teresa Tejedor Lourdes Palacios César Martín Ana Cenarro 《Revista espa?ola de cardiología》2021,74(8):664-673
Introduction and objectivesOur objective was to approximate the prevalence of mutations in candidate genes for familial hypercholesterolemia (FH) in a middle-aged Spanish population and to establish the predictive value of criteria for clinical suspicion in the detection of causative mutations.MethodsUnrelated individuals aged ≥ 18 years from the Aragon Workers’ Health Study (AWHS) with high low-density lipoprotein cholesterol (LDL-C) and clinical suspicion of FH (participants with LDL-C concentrations above the 95th percentile, participants with premature cardiovascular disease and/or participants with high LDL-C [130 mg/dL] under statin therapy), assuming that any participant with FH exhibits at leats 1 trait, were selected and the LDLR, APOB, PCSK9, APOE, STAP1 and LDLRAP1 genes were sequenced by next generation sequencing technology.ResultsOf 5400 individuals from the AWHS, 4514 had complete data on lipid levels and lipid-lowering drugs, 255 participants (5.65%) met the criteria for suspicion of FH, 24 of them (9.41%) were diagnosed with hyperlipoproteinemia(a), and 16 (6.27% of those sequenced) were found to carry causative mutations in candidate genes: 12 participants carried 11 different pathogenic LDLR alleles and 4 participants carried 1 pathogenic mutation in PCSK9. LDL-C concentrations > 220 mg/dL and LDL-C > 130 mg/dL despite statin therapy showed the strongest association with the presence of mutations (P = .011).ConclusionsOur results show that the prevalence of FH in Spain is 1:282 and suggest that the combination of high untreated LDL-C and high levels of LDL-C despite statin therapy are the best predictors of a positive FH genetic test. 相似文献
247.
Pardo A Durández R Hernández M Pizarro A Hombrados M Jiménez A Planas R Quintero E 《The American journal of gastroenterology》2002,97(6):1535-1542
OBJECTIVE: Upper GI bleeding (UGIB) is a common medical emergency that leads to a high consumption of medical resources and costs. We aimed to analyze the influence of physician specialty on the costs of nonvariceal UGIB care. METHODS: We retrospectively assessed 350 nonvariceal UGIB episodes that were primarily cared for by gastroenterologists (n = 142), internists (n = 67), or surgeons (n = 141). Gastroenterologists followed evidence-based clinical protocols that included early endoscopy and early hospital discharge for uncomplicated bleeding. A risk score system was used to control for severity of illness. Linear regression analyses were performed to find out predictors of costs and the influence of specialist care on length of stay (LOS). RESULTS: The overall mean hospital cost was significantly lower in patients cared for by gastroenterologists (EUR 1,630) than in those managed by internists (EUR 3,745, p < 0.001) or surgeons (EUR 2,513, p < 0.05). The mean LOS was the variable with highest influence on total cost. Patients cared for by gastroenterologists had a mean LOS significantly shorter (7.3 days) than that of those treated by internists (16.2 days, p < 0.001) or surgeons (11 days, p < 0.001). Hospital costs and LOS differences were maintained when adjusting for severity of illness. In caring for low risk patients, nongastroenterologists had a higher probability of having a hospital stay longer than 4 days (odds ratio = 18.4, Cl = 4.6-73.6, p < 0.001). CONCLUSION: The implementation of specific evidence-based protocols by gastroenterologists reduces length of hospital stay and saves medical costs in patients with nonvariceal UGIB, especially those at low risk. 相似文献
248.
249.
González Hernández E Cabadés O'Callaghan A Cebrián Doménech J López Merino V Sanjuán Mañez R Echánove Errazti I Valencia Martín J Bertomeu Martínez V;Investigadores del estudio PRIMVAC 《Revista espa?ola de cardiología》2004,57(1):12-19
INTRODUCTION AND OBJECTIVES: Some authors have described seasonal variations in the incidence of acute myocardial infarction. The aim of this study was to determine the existence of seasonal rhythms in admissions for acute myocardial infarction to coronary care units, and in mortality, and to analyze the influence of age on environmental factors. PATIENTS AND METHOD: The study included a total of 8400 consecutive patients with acute myocardial infarction admitted to 12 coronary care units in the PRIMVAC registry from January 1995 to December 1999. Seasonal rhythms were analyzed with the time series method and the Cosinor regression equation. The influence of age was analyzed with the chi 2 test. RESULTS: The total number of admissions increased in winter and decreased in summer. The highest peak (acrophase) occurred in winter, with 2183 cases (r2=0.91), specifically in February, with 742 cases (r2=0.66). The age of the patients conditioned seasonal variations (P=.006), and the influence was statistically significant for patients over 65 years of age. Changes in mortality with time did not reach statistical significance. CONCLUSIONS: A seasonal rhythm in admissions for acute myocardial infarction was found, with an increase in winter and a decrease in summer. Age conditioned the effect of environmental factors on acute myocardial infarction, and patients aged 65 years or older were more sensitive to mechanisms that led to increases in admissions in winter. 相似文献
250.
Alfonso F García P Pimentel G Hernández R Sabaté M Escaned J Bañuelos C Fernández C Macaya C;Intravascular ultrasound study 《American heart journal》2003,145(2):254-261
Background Residual plaque burden after coronary stenting may be visualized by use of intravascular ultrasound. Determinants and implications of residual atherosclerotic plaque burden after coronary stenting are not well established. In particular, the implications of residual plaque burden, after adjusting for confounding factors, are still unknown. Methods Sixty-two consecutive patients (age 56 ± 9 years) undergoing coronary stenting under intravascular ultrasound imaging guidance were prospectively studied. A total of 616 slices were analyzed (every 2 mm of stent length) from motorized pull-back recordings. Residual plaque burden was calculated as residual plaque/vessel area × 100. Results In 565 slices (89%), both residual plaque area and stent area could be measured. Mean residual plaque burden was 46.5% ± 6%. By use of multiple regression analysis, lesion plaque area and reference segment plaque burden were identified as independent predictors of residual plaque burden after stenting. In addition, a significant correlation was found between residual plaque burden and most relevant angiographic parameters at follow-up (including minimal lumen diameter, percent diameter stenosis, and loss index), which persisted after adjustment. Furthermore, stents with a residual plaque burden ≥46% had higher a restenosis rate (relative risk [RR] 4.4, 95% CI 1.09-18.2, P = .03). On logistic regression analysis, residual plaque burden (RR 4.8, 95% CI 4.1-5.6, P = .01) and diabetes (RR 4.3, 95% CI 3.6-5.1, P = .03) emerged as the only independent predictors of restenosis. Conclusions The amount of residual plaque burden after coronary stenting plays an independent role on the late angiographic outcome of these patients. (Am Heart J 2003;145:254-61.) 相似文献